Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania
East African Health Research Journal · 04.11.2026 · 10 (2)
DOI: 10.24248/eahrj.v10i2.339 ↗Kurz gefasst
Fachartikel in der Zeitschrift East African Health Research Journal, online erschienen am 04.11.2026. Verfasst von Lilian Nkinda und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Coronavirus Disease 2019 has become endemic and is no longer a global health emergency. However, it remains significant for people living with HIV, whose immune dysregulation may impact antibody responses. Hence this study assessed neutralizing antibody capacity against SARS-CoV-2 variants among HIV-infected adults in Tanzania to inform sero-surveillance and pandemic readiness.
Methods
Seventy HIV-positive adults (≥18 years) were enrolled (53 vaccinated, 17 unvaccinated). These were compared with 89 individuals who were HIV negative (71 vaccinated and 18 unvaccinated). Neutralizing antibodies were quantified using a surrogate virus neutralization assay, with ≥27.7% inhibition defined as protective. Factors associated with neutralization were analyzed using modified Poisson regression (STATA v15), and group differences assessed using Kruskal-Wallis tests (Prism 9), with significance at P< .05.
Results
Our study observed a progressive decline in the proportion of participants with protective neutralizing antibodies across the SARS-CoV-2 variants, that is; 93% (65/70) for the wild-type (WT), 77% (54/70) for Delta, and 54% (38/70) for Omicron whether vaccinated or unvaccinated. Additionally, no significant difference in neutralising antibody inhibition capacity was found between participants with CD4 counts above 500 and those below, for any of the three variants, P>.9999. Also, the median percentage of neutralizing capacity among the relatively healthy HIV infected individuals (>500 CD4 count) was lower (28%) compared those who were HIV negatives (98%), within the vaccinated group (P
Zitieren
APA
Nkinda, L., Lyamuya, E., Ueno, T., Senkoro, M., Mfinanga, S., Kidenya, B., Kisuse, J., Hassan, F. E., Kamori, D., Nkuwi, E., Barabona, G., Masoud, S., Shayo, V., & Balandya, E. (2026). Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania. East African Health Research Journal, 10(2). https://doi.org/10.24248/eahrj.v10i2.339
Vancouver
Nkinda L, Lyamuya E, Ueno T, Senkoro M, Mfinanga S, Kidenya B, et al. Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania. East African Health Research Journal. 2026;10(2). doi:10.24248/eahrj.v10i2.339
BibTeX
@article{Nkinda2026,
author = {Nkinda, Lilian and Lyamuya, Eligius and Ueno, Takamasa and Senkoro, Mbazi and Mfinanga, Sayoki and Kidenya, Benson and Kisuse, Juma and Hassan, Frank Eric and Kamori, Doreen and Nkuwi, Emmanuel and Barabona, Godfrey and Masoud, Salim and Shayo, Victoria and Balandya, Emmanuel},
title = {Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania},
journal = {East African Health Research Journal},
year = {2026},
volume = {10},
number = {2},
doi = {10.24248/eahrj.v10i2.339}
}
EUVIMED